Pseudomonas species are enormously important in human infections, in biotechnology, and as model systems for investigating basic science questions. In this study, we have developed a xylose-inducible promoter system, evaluated it in P. aeruginosa and P. fluorescens, and found it to be suitable for the strong induction of gene expression. Furthermore, we have demonstrated its efficacy in controlled gene expression to show that a type II secretion system protein from P. aeruginosa, XcpQ, is important for host-pathogen interactions in a corneal wound closure model.
KEYWORDS: Pseudomonas, inducible promoter, plasmids, xylose
ABSTRACT
Tunable control of gene expression is an invaluable tool for biological experiments. In this study, we describe a new xylose-inducible promoter system and evaluate it in both Pseudomonas aeruginosa and Pseudomonas fluorescens. The Pxut promoter, derived from the P. fluorescens xut operon, was incorporated into a broad-host-range pBBR1-based plasmid and was compared to the Escherichia coli-derived PBAD promoter using gfp as a reporter. Green fluorescent protein (GFP) fluorescence from the Pxut promoter was inducible in both Pseudomonas species, but not in E. coli, which may facilitate the cloning of genes toxic to E. coli to generate plasmids. The Pxut promoter was activated at a lower inducer concentration than PBAD in P. fluorescens, and higher gfp levels were achieved using Pxut. Flow cytometry analysis indicated that Pxut was leakier than PBAD in the Pseudomonas species tested but was expressed in a higher proportion of cells when induced. d-Xylose as a sole carbon source did not support the growth of P. aeruginosa or P. fluorescens and is less expensive than many other commonly used inducers, which could facilitate large-scale applications. The efficacy of this system was demonstrated by its use to reveal a role for the P. aeruginosa type II secretion system gene xcpQ in bacterial inhibition of corneal epithelial cell wound closure. This study introduces a new inducible promoter system for gene expression for use in Pseudomonas species.
IMPORTANCE Pseudomonas species are enormously important in human infections, in biotechnology, and as model systems for investigating basic science questions. In this study, we have developed a xylose-inducible promoter system, evaluated it in P. aeruginosa and P. fluorescens, and found it to be suitable for the strong induction of gene expression. Furthermore, we have demonstrated its efficacy in controlled gene expression to show that a type II secretion system protein from P. aeruginosa, XcpQ, is important for host-pathogen interactions in a corneal wound closure model.
INTRODUCTION
Species of the bacterial genus Pseudomonas are of exceptional importance, not only as infectious agents for a broad range of organisms, including humans and plants (1–4), but also for the valuable role that species of this genus play in biotechnology and basic science (5, 6). Inducible gene expression systems are important tools in both biotechnology and basic science that enable tunable expression in the presence of an effector molecule.
Inducible plasmid systems for pseudomonads include the l-arabinose-inducible, AraC-regulated PBAD promoter from Escherichia coli, which is inducible in Pseudomonas aeruginosa (7–9). Whereas this promoter has proven useful for gene expression in numerous studies, it has been demonstrated to be leaky without induction in P. aeruginosa (10). Other inducible promoter systems in P. aeruginosa include the lacIq-Ptac and the rhaSR-PrhaB promoter (10, 11). While lacIq-Ptac and rhaSR-PrhaB confer tightly controlled gene expression when inserted into the chromosome (10), the rhaSR-PrhaB system is large (>2,000 bp), and the lacIq-Ptac system uses a high-cost inducer. Therefore, there would be value in the development of a small-size, low-cost system for gene expression from episomal plasmids.
The goal of this study was to develop an episomal-plasmid-based inducible promoter system for Pseudomonas species using pseudomonad-derived DNA. This study describes the evaluation of the Pseudomonas fluorescens xutR-PxutA promoter system (here designated Pxut) in both P. aeruginosa and P. fluorescens. In addition, we use this system to interrogate P. aeruginosa host-pathogen interactions, particularly the mechanisms underlying bacterial inhibition of corneal epithelial cell wound closure (12).
RESULTS
Identification and cloning of a putative xylose-inducible promoter from P. fluorescens.
A putative xylose metabolism transcription factor gene, Pf101_2304, was identified in the P. fluorescens strain Pf0-1 genome by BLAST analysis (13). Recently, the homolog of this gene in P. fluorescens strain SBW25 was demonstrated to encode an activator of a xylose metabolism operon and was named XutR by Liu et al. (14). In strain SBW25, the XutR protein was demonstrated to directly and positively regulate transcriptional expression of the adjacent gene, xutA, in a xylose-dependent manner, and bound to a conserved operator site (AAAATC-N15-GATTTTT) upstream of xutA (14). In the SBW25 genome, the intergenic region between xutR and xutA is 139 bp long, whereas it is 182 to 188 bp long in P. fluorescens strain Pf0-1, depending on whether a TTG or an ATG for xutA is the start codon. Other differences in the intergenic region between strains SBW25 and Pf0-1 include a direct repeat of CCAAGAACAACAA just upstream of the ribosome binding site in Pf0-1 that is present in a single copy in SBW25. A schematic diagram and sequence for the intergenic region of strain Pf0-1 are presented in Fig. 1A and B. The xutR and intergenic regions with the promoter for xutA (here designated Pxut) from strain Pf0-1 were cloned into a pBBR1-based broad-host-range plasmid, pMQ132 (11), with gfp placed under the control of Pxut (Table 1). A diagram of the resulting plasmid, pMQ578, is shown in Fig. 1C and Fig. S1A in the supplemental material.
TABLE 1.
Strain or plasmid | Description | Reference or source |
---|---|---|
Strains | ||
S17-1 λ-pir | E. coli laboratory strain | 46 |
PIC3611 | S. marcescens, wild type | Presque Isle Cultures |
PAO1 | P. aeruginosa, wild type | 47 |
PA14 | P. aeruginosa UCBPP-PA14, wild type | 48 |
PAC | P. aeruginosa, keratitis isolate | 49 |
Pf0-1 | P. fluorescens wild-type strain | 50 |
Plasmids | ||
pMQ80 | Shuttle vector, pRO1600 with PBAD-gfpmut3 | 8 |
pMQ132 | Shuttle vector, pBBR1; Plac-lacZ aacC-1 | 11 |
pMQ414 | Shuttle vector, RSF1010; PnptII-tdtomato aacC-1 | 43 |
pMQ578 | pMQ132 with xutR-Pxut-gfp replacing Plac-lacZ | This study |
pMQ643 | pMQ578 with tdtomato replacing gfp | This study |
pMQ644 | pMQ578 with xcpQ from PA14 replacing gfp | This study |
pMQ650 | pMQ578 with multicloning site replacing gfp | This study |
pMQ652 | pMQ650 with yeast replicon removed | This study |
The pMQ578 plasmid has an RP4 oriT sequence for conjugal transfer, the aacC-1 gentamicin resistance marker, and a selectable marker and replicon for Saccharomyces cerevisiae to allow for in vivo yeast cloning (8). We used a previously described plasmid with the E. coli PBAD promoter driving gfp, pMQ80 (8), as a comparison promoter, since the PBAD promoter is frequently used for gene expression in E. coli and Pseudomonas species. The resulting plasmids were used to characterize Pxut expression in E. coli and two species of Pseudomonas.
Characterization of Pxut expression in E. coli, P. aeruginosa, and P. fluorescens.
To evaluate Pxut and PBAD expression, pMQ578 and pMQ80 were introduced into E. coli strain S17-1, P. aeruginosa strain PA14, and P. fluorescens strain Pf0-1. Increasing doses of l-arabinose and d-xylose were added to cultures (optical density at 600 nm [OD600], 0.01), and the cultures were analyzed for green fluorescent protein (GFP) fluorescence using a fluorometer after 25 h of incubation at 30°C or 37°C. After the addition of an inducer, with E. coli, no fluorescence was measured with Pxut-gfp compared to the absence of an inducer, whereas PBAD was inducible at low concentrations (0.1 mM) of l-arabinose (Fig. 2A). In P. aeruginosa, both Pxut-based expression and PBAD-based expression were dose dependent, and the Pxut promoter was slightly stronger than PBAD at intermediate inducer doses (Fig. 2B). With P. fluorescens, both promoters were inducible, but the Pxut promoter was inducible at lower concentrations than the PBAD promoter and was stronger at all doses (Fig. 2C).
The expression of both promoters was tested over time using 10 mM inducer (Fig. 3A to C). Cultures with an inducer were started at an OD600 of 0.01 and were allowed to grow at 30°C. Samples were removed and analyzed for GFP fluorescence over time. GFP fluorescence was largely undetected until 6 h postinduction and was maximal at the final time point (25 h). The highest fluorescence levels were observed with Pf0-1 and Pxut (pMQ578) at 25 h (Fig. 3C).
The fold induction of GFP fluorescence was calculated for cultures with 10 mM inducer relative to no inducer. For PBAD, the highest induction was for E. coli, with a 46 ± 36-fold increase, compared to 19 ± 3-fold and 27 ± 9-fold for Pf0-1 and PA14, respectively. With Pxut, GFP levels were unchanged for E. coli, with a ratio of 1.03 ± 0.2 for 10 mM xylose relative to no xylose, but were 51 ± 22-fold and 38 ± 20-fold increased for Pf0-1 and PA14, respectively.
The Pxut promoter was evaluated in additional P. aeruginosa isolates: the widely used strain PAO1 and the clinical keratitis isolate PAC. With 10 mM xylose, GFP fluorescence in both strains was induced and notably higher than that observed for strain PA14 at the same concentration (compare Fig. S2A with Fig. 5B). The fold induction was calculated and was found to be highest for PAO1 among the three strains, at 55-fold with xylose relative to no inducer (Fig. S2B).
Because P. aeruginosa is often studied at 37°C due to its role as a human pathogen, we tested the inducibility of Pxut at 37°C with xylose (10 mM) by using strains PAO1 and PA14. In results similar to those obtained at 30°C, xylose induced GFP production at 37°C. No significant differences were found between the two temperatures in terms of fold induction for either strain, with >50-fold induction for PAO1 and 23- to 35-fold induction for PA14 (Fig. S3).
The utilization of an inducer as a carbon source by bacteria can reduce the efficacy of the inducer in a culture over time. We tested the abilities of PA14 and Pf0-1 to grow in minimal medium with l-arabinose or d-xylose as a sole carbon source at 10 mM. Glucose at 10 mM was used as a positive control (Fig. 4). After 24 h of growth at 30°C, culture density was measured with a spectrophotometer. Pf0-1 grew with arabinose or glucose, but not with xylose, as a sole carbon source. PA14 grew only with glucose as a carbon source.
Ribose was also shown to be an inducer of Pxut in strain SBW25 (14); therefore, we evaluated ribose as an inducer of bacteria with pMQ578 (Fig. 5). After 25 h of growth at 30°C, PA14 showed a 19% increase in GFP fluorescence with 10 mM ribose relative to no ribose, and a 93% increase was observed with 100 mM ribose (1,723 ± 219 relative fluorescence units [RFU] without ribose, 2,050 ± 265 RFU with 10 mM, and 3,335 ± 464 RFU with 100 mM). For Pf0-1, we observed a 25% increase in fluorescence at 10 mM and a 41% increase at 100 mM ribose (2,074 ± 172 RFU without ribose, 2,597 ± 200 RFU with 10 mM, and 2,919 ± 219 RFU with 100 mM). These findings suggest that ribose would have limited utility as an inducer of Pxut relative to xylose in the two strains tested unless controlled, low levels of gene expression are required for an experiment (Fig. 5A).
We further tested whether ribose would have a negative impact on induction by xylose (Fig. 5B). P. aeruginosa with pMQ578 was exposed to xylose and ribose independently or as a mixture, and the GFP fluorescence levels of cultures incubated with xylose alone or both xylose and ribose at 10 mM were indistinguishable (P, >0.05 by analysis of variance [ANOVA]), demonstrating that ribose does not prevent the induction of the xut promoter by xylose under the conditions tested.
A similar lack of induction of the Pxut promoter was observed with the Serratia marcescens laboratory strain PIC3611. GFP fluorescence was measured at 727 ± 144 RFU with xylose (10 mM) and at 488 ± 320 RFU without xylose (P = 0.22; n = 4). Similar results were observed in preliminary experiments with Klebsiella pneumoniae and another E. coli strain, MIC4100. These data suggest that, for reasons unknown at this time, Pxut is not expressed in the Enterobacteriaceae.
Comparison of PBAD and Pxut for induction of genes during stationary phase.
Next, we investigated whether the PBAD and Pxut promoters were responsive to inducers for cultures in the stationary phase (Fig. 6). We tested the expression of PBAD-gfp and Pxut-gfp in stationary-phase cultures to which an inducer was added (10 mM) as a function of time. Pf0-1 and PA14 cultures were grown overnight, washed with phosphate-buffered saline (PBS) to remove residual LB medium, and diluted to an OD600 of 2 in PBS with an inducer. While we do not expect researchers to culture bacteria in PBS for gene expression experiments, PBS was used to prevent significant additional growth and to keep the bacteria in a stationary-phase-like state. Modest induction was shown by 6 h in stationary-phase cultures incubated in PBS relative to actively growing cultures (Fig. 6). At the final time point, Pxut in Pf0-1 demonstrated the greatest induction of GFP fluorescence, with 5.5 ± 1.4-fold higher fluorescence than Pf0-1 with PBAD (Fig. 6). This suggests that the Pxut promoter could be used in stationary-phase cultures, and perhaps biofilms, for the expression of desired genes.
Flow cytometry analysis of promoter activity in Pseudomonas species.
Previous studies have indicated that under many conditions, the PBAD promoter is expressed only in a subset of cells of an induced population of E. coli (15–17). Here, we evaluated the PBAD and Pxut promoters in PA14 and Pf0-1 by using flow cytometry analysis to assess promoter leakiness and to determine the frequency of cells in which gene expression is activated upon the addition of a moderate level of an inducer (10 mM). The data in Fig. 7 and Fig. 8A demonstrate a higher level of leakiness for Pxut than for PBAD in both PA14 and Pf0-1. For both species, the Pxut promoter produced higher fluorescence intensity in induced GFP-positive cells than the PBAD promoter (2.5 ± 8-fold and 2.3 ± 0.5-fold for P. fluorescens and P. aeruginosa, respectively) (Fig. 8B). Higher fluorescence intensity was observed for Pf0-1 with both promoters, but this may be due to the larger cell size of Pf0-1 than of PA14 (P, <0.001 by ANOVA with Tukey’s posttest). The cell length for PA14 was measured at 1.8 ± 0.5 or 1.6 ± 0.4 μm when the strain was grown in LB with xylose or arabinose at 10 mM, respectively (n, ≥50 cells per group). The cell length for Pf0-1 was measured at 2.5 ± 0.7 or 2.4 ± 0.6 μm when the strain was grown in LB with xylose or arabinose at 10 mM, respectively (n, ≥50 cells per group).
Additional shuttle vectors with Pxut.
The pMQ578 vector with Pxut-gfp did not have a convenient restriction site at the 5′ end of the gfp gene, which would impede the replacement of gfp with another gene using traditional cloning methods. To make more user-friendly constructs, the gfp gene was replaced with tdtomato flanked by restriction sites to produce pMQ643 and with a multicloning site containing six unique restriction sites to produce pMQ650 (Table 1 and Fig. S1). The pMQ643 plasmid was introduced into Pf0-1, which was grown with or without xylose (10 mM). The culture with xylose was significantly brighter than the culture without xylose (P, 0.016 by an unpaired t test); tdTomato fluorescence/OD600 values for cultures with xylose were 1.3 × 105 ± 7.2 × 104 versus 2.0 × 103 ± 1.7 × 103 for the same culture conditions without xylose.
The pMQ650 plasmid was additionally modified by removing the yeast replicon for the benefit of researchers who do not use yeast recombineering. The resulting plasmid, pMQ652, is 5.4 kbp rather than 7.3 kbp (Table 1, Fig. 1C, and Fig. S1B).
Use of the Pxut promoter system to evaluate the impact of P. aeruginosa corneal epithelial cell wound closure in vitro.
A previous study demonstrated that secreted factors from P. aeruginosa strain PA14 could inhibit corneal cell migration and wound healing (12). To gain insight into the mechanism by which a secreted factor(s) from P. aeruginosa inhibits corneal wound healing, we first heat-treated normalized secretomes from strain PA14. Whereas unheated secretomes inhibited wound healing, those heated for 10 min at 95°C were unable to inhibit corneal cell migration (data not shown). This result suggested that the inhibitory secreted factor was a heat-labile molecule, such as a protein.
P. aeruginosa has numerous secretion systems. We reasoned that the secreted inhibitor factor was unlikely to be secreted by type III or type VI secretion systems, because contact between P. aeruginosa and the corneal cells was not necessary for the cell migration phenotype (only culture filtrates were used). Because many enzymes are secreted through the type II secretion system of P. aeruginosa (18), we used a strain deficient in XcpQ to test whether the type II secretion system was required for inhibiting cell migration. The XcpQ protein is an essential component of the type II secretion system and forms part of the outer membrane pore (18).
Unlike wild-type PA14 culture filtrates, those from a previously described ΔxcpQ derivative of PA14 (19) were unable to block cell migration (Fig. 9). Expression of xcpQ, but not gfp (used as a negative control) from Pxut, was able to restore the cell migration inhibition phenotype to the xcpQ mutant in a d-xylose-dependent manner; that is, 50 mM (but not 5 mM) d-xylose was sufficient to complement the cell migration inhibition phenotype (Fig. 9). Importantly, as a control, d-xylose (50 mM) did not restore the cell migration inhibition phenotype to the ΔxcpQ mutant that did not have a plasmid, indicating that d-xylose alone was not responsible for the phenotype in the absence of the xcpQ plasmid (data not shown). These results indicate that the P. aeruginosa type II secretion system is necessary for the inhibition of corneal wound healing and demonstrate the utility of the Pxut system for studying Pseudomonas biology.
DISCUSSION
This study introduces a new inducible promoter system for pseudomonads. The new Pxut promoter had no detectable function in E. coli. This could be considered a disadvantage of the Pxut promoter, because one cannot use the same plasmid construct to express genes in E. coli and a Pseudomonas species. However, since plasmids are almost exclusively passed through E. coli before moving into Pseudomonas species, genes that are toxic to E. coli are likely to be more easily cloned with Pxut than with other promoter systems that might have leaky expression in E. coli. For P. aeruginosa, the Pxut promoter appeared to be largely equivalent to PBAD, although it was leakier, and there was a tendency toward higher expression with Pxut on a population basis (Fig. 2) and in GFP-positive fluorescent cells, but this did not reach significance (Fig. 7 and 8). In P. fluorescens, the Pxut promoter performed better than PBAD with respect to maximal expression levels and required a lower concentration of inducer for expression (Fig. 2C, 7, and 8). One caveat in comparing the Pxut and PBAD promoters in these Pseudomonas species is that pMQ80 has a pRO1600 origin of replication and pMQ578 has a pBBR1 origin of replication. While these have been reported to support similar copy numbers (20–22), this feature is an additional variable. In addition to xylose, Pxut can be activated by ribose (14), raising the possibility that the Pxut promoter can be fine-tuned with these alternative carbohydrate inducers.
Pseudomonas species have been suggested for industrial production and bioremediation of molecules, including, but not limited to, β-peptides (23), polyhydroxyalkanoates (24), phenazine-1-carboxyamide (25), proteases (26, 27), pseudofactin (28), rhamnolipids (29–31), silver nanoparticles (32), and toluene (33). The ability of Pxut to activate gene expression in the majority of cells and its relative strength in P. fluorescens compared to PBAD suggest that it may be useful for large-scale gene synthetic applications. These advantages are further strengthened by the low cost of d-xylose relative to other inducers; l-arabinose and isopropyl-β-d-thiogalactopyranoside (IPTG) cost approximately 10 times more to induce a culture (with 10 mM sugar or 0.1 mM IPTG). An additional benefit of d-xylose is that it is not usable as a carbon source by either of the Pseudomonas species tested, indicating that the d-xylose inducer will not be catabolized for energy and thereby eliminated from the culture over time.
Xylose-inducible plasmid systems have been developed for a number of other Gram-negative bacteria, such as Caulobacter crescentus (34), and for Gram-positive species, including Bacillus subtilis, Clostridioides difficile, Lactococcus lactis, Staphylococcus xylosus, and Streptomyces lividans (35–39). The xylose-responsive transcription factors for these systems include members of the AraC family, such as XutR, used in this study, LacI, MarR, and the ROK family. The fold induction ranges from ∼10-fold, as is the case with C. crescentus, up to several orders of magnitude for B. subtilis and C. difficile. While the fold induction values for the different systems are not clearly comparable, because the developers used different reporters, media, induction times, and other variables, taken at face value, they put Pxut in the low to middle range of these expression systems.
With regard to corneal epithelial wound closure, previous work has implicated lipopolysaccharide from E. coli and Serratia marcescens in the inhibition of corneal wound healing (12, 40). Unlike that of P. aeruginosa, the secreted inhibitory factor from S. marcescens was heat stabile (12). Work with the Pxut promoter in this study strongly implicated the type II secretion system of P. aeruginosa strain PA14 in allowing the bacterium to inhibit corneal epithelial wound closure, which may increase its ability to establish ocular infections.
In summary, we have created an episomal-plasmid-based, xylose-inducible expression system and tested it in P. aeruginosa and P. fluorescens. The Pxut promoter region, including the ribosome binding site and regulatory gene, spans 1,356 bp, in contrast to >2,042 bp for the rhaSR-PrhaB system, making Pxut well suited for use on an episome. The Pxut system is likely leakier without an inducer than lacIq-Ptac and rhaSR-PrhaB, but this has yet to be tested in controlled experiments. Nevertheless, the Pxut system presented here should be useful for the inducible expression of genes in Pseudomonas species by itself or in conjunction with other inducible systems.
MATERIALS AND METHODS
Strains, media, and growth conditions.
Bacterial strains and plasmids are listed in Table 1. Bacteria were grown in lysogeny broth (LB) (41) and were aerated on a TC-7 tissue culture roller (New Brunswick, Inc). P. aeruginosa strains are listed in Table 1. Gentamicin was used at 10 μg/ml in E. coli and 30 μg/ml in Pseudomonas species to select for plasmids. Bacterial culture density was measured with a 1-cm cuvette using a SpectraMax M3 plate reader, except where noted below.
Plasmid construction.
Plasmids are listed in Table 1, and oligonucleotide primers and synthetic DNA sequences are listed in Table 2. Plasmids were made using yeast homologous recombination (8), except for pMQ652, and were verified by PCR and sequencing of junctions. The xutR gene and the intergenic region between xutR and xutA from the Pseudomonas fluorescens Pf0-1 genome were cloned along with gfpmut3 (gfp) (42) from pMQ80 (8) to replace Plac and lacZα from pMQ132 (11). The resulting plasmid, pMQ578, and all plasmids made in this study are listed in Table 1. One variant of pMQ578 was made in which gfp was replaced with tdtomato from pMQ414 (43) using primers 4127 and 4218; this variant was named pMQ643. For another variant, pMQ650, an artificial DNA sequence containing six restriction enzyme sites (EcoRI, SalI, BamHI, SpeI, SphI, and HindIII) and a sequence with stop codons in three frames was introduced using a 499-bp double-stranded DNA sequence listed as primer 4168 (gBlock; IDT, Inc.). The pMQ650 plasmid was sequenced using the PacBio platform (coverage of 32) by SNPSaurus (Eugene, OR). Last, pMQ652 was made by the digestion of pMQ650 with SspI and StuI, which excises a 1.8-kba region containing the yeast replicon and the URA3 gene, followed by recircularization with T4 DNA ligase.
TABLE 2.
Oligonucleotide primer | Sequencea |
---|---|
3821 Pxut | ccagtgaaaagttcttctcctttactcatatgtatatcTCCTTGTTGTTCTTGGTTGTTG |
3822 Pxut | atgcagctggcacgacaggtttcccgactggaaagcggCAGGACACGGCGCGTATTCTCC |
4127 Pxut-tdtomato | aacagccaagcttgcatgcctgcagactagtcggatccTTACTTGTACAGCTCGTCCATG |
4128 Pxut-tdtomato | caagaacaacaaccaagaacaacaaggagaattctttttATGGTGAGCAAGGGCGAGGAG |
4132 xcpQ | gccaaaacagccaagcttgcatgcctgcagactagtTTATTCCGTCTTCAGTTCGCGCAG |
4133 xcpQ | acaacaaccaagaacaacaaggagatataATGTCCCAACCTTTGCTCCGCGCCCTGTTTG |
4168 Pxut-MCS | ctactgccgccaggcaaattctgttttatcagaccgcttctgcgttctgatttaatctgtatcaggctgaaaatcttctctcatccgccaaTTATTCTATTTACCAAGCTTGCATGCGACTAGTTGGATCCTTGGGTCGACCGAAGAATTCAAAAATCctccttgttgttcttggttgttgttcttgggcgtgtcccgatactagcaacggccctgtgcctgccgattacgaaaatcaccaacacgcagtgcgattttgcgtattgagattcgccctctgcgcgcctagtctgtgcagaccgcctctacggcaagaggcccggaacaagcctgaaaacaatgaaaaccgtaccgcctgttcaccgcatcgccctgttgttcaacggcagcaagatctatgaccgcggcatcatcagcggcatcggcaactacctgagcagcacgcgcgcgtcttgggacctgtttctggaagaggattttctctgccgcttgaaaggta |
Capital letters indicate sequence that directs priming, except for oligonucleotide 4168, where capital letters indicate the sequence that replaced GFP on pMQ578. Lowercase letters indicate sequence that directs recombination.
Fluorescence assays.
Bacteria were grown as described above, and at various time points, samples were obtained for analysis. Aliquots (150 μl) were read in 96-well plates with black opaque sides and clear bottoms (catalog no. 165305; Thermo Scientific Nunc). GFP fluorescence and tdTomato fluorescence were read with a BioTek Synergy 2 plate reader using 485/20 excitation and 516/20 emission filters for GFP and 545/40 excitation and 590/20 emission filters for tdTomato. Optical density was read at 600 nm.
Flow cytometry analysis of GFP fluorescence.
Bacteria were grown overnight with or without 10 mM inducer, adjusted to an OD600 of 2, washed twice, and adjusted to an OD600 of 0.02 in phosphate-buffered saline (PBS) that had been filtered with a 0.22-μm filter. Flow cytometric analysis was performed on a CytoFLEX LX instrument (Beckman Coulter, USA). Filtered PBS was used as a negative control for gating bacteria by forward scatter (FSC) and side scatter (SSC). Approximately 105 cells were analyzed per genotype, and the experiments were repeated on five occasions. Bacteria of each species without the fluorescent plasmid were used as negative controls to determine the FSC threshold, as well as for background fluorescence cutoff. Software analysis was performed using FlowJo, version 10 (Becton, Dickinson, USA).
Corneal cell migration analysis.
In vitro epithelial cell wound closure assays were performed as described previously (12) using human corneal limbal epithelial (HCLE) cells (44) and a commercial wound-healing assay kit (Oris; product no. CMAU101; Platypus Technologies, LLC). After stratified cell layers of HCLE cells were established (45), they were challenged with 50 μl of normalized bacterial culture filtrates or LB medium that was added to 100 μl of culture medium overlaid on the cells. The tissue culture medium consisted of stratification medium or keratinocyte serum-free medium (catalog no. 10724-011; Gibco) supplemented with bovine pituitary extract (25 μg/ml), epidermal growth factor (0.2 ng/ml), and penicillin and streptomycin at 100 μg/ml. Bacterial culture filtrates were made using overnight cultures of P. aeruginosa grown in LB medium with or without xylose and antibiotic and were incubated at 30°C. Cultures were adjusted to an OD600 of 1.0 using fresh LB medium and were filtered with a 0.22-μm filter (Mellex-GV polyvinylidene difluoride [PVDF]). After 20 to 24 h, HCLE cells were rinsed with PBS and were stained using 0.5 μM Calcein AM (catalog no. C3099; Invitrogen) for 15 min. Cells were imaged using an Olympus FluoView FV-1000 laser scanner confocal microscope with a 4× (numerical aperture [NA], 0.3) objective and were analyzed with FluoView image-viewing software.
Bacterial length analysis.
Bacteria were grown in LB medium with or without inducer (arabinose or xylose at 10 mM) for 24 h. Bacteria were then imaged as described above, but using a 60× objective. Bacteria were measured using ImageJ software, and at least 50 cells were counted from two different experiments per group.
Statistical analysis.
Experiments were performed at least three times, and data were analyzed with GraphPad Prism software using ANOVA, two-way ANOVA, and Student t tests.
Data availability.
The annotated pMQ650 plasmid sequence has been deposited in GenBank under accession number MT344942. The DNA sequences of the xutR and Pxut regions from pMQ578, corresponding to genome coordinates 2656767 to 2656949 from the Pf0-1 genome, have been deposited in GenBank under accession number MN857504.
Supplementary Material
ACKNOWLEDGMENTS
We thank Nancy Baker for expert help with flow cytometry and George O’Toole at Dartmouth Medical School for gifts of strains.
This study was supported by the Charles T. Campbell Laboratory of Ophthalmic Microbiology, NIH grants EY027331 (to R.M.Q.S.) and EY08098 (Core Grant for Vision Research), and the Eye and Ear Foundation of Pittsburgh, as well as by unrestricted funds from Research to Prevent Blindness.
Footnotes
Supplemental material is available online only.
REFERENCES
- 1.Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2:1051–1060. doi: 10.1016/s1286-4579(00)01259-4. [DOI] [PubMed] [Google Scholar]
- 2.Martinez-Gil M, Ramos C. 2018. Role of cyclic di-GMP in the bacterial virulence and evasion of the plant immunity. Curr Issues Mol Biol 25:199–222. doi: 10.21775/cimb.025.199. [DOI] [PubMed] [Google Scholar]
- 3.Moradali MF, Ghods S, Rehm BH. 2017. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol 7:39. doi: 10.3389/fcimb.2017.00039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.O’Callaghan R, Caballero A, Tang A, Bierdeman M. 2019. Pseudomonas aeruginosa keratitis: protease IV and PASP as corneal virulence mediators. Microorganisms 7:281. doi: 10.3390/microorganisms7090281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kim J, Salvador M, Saunders E, González J, Avignone-Rossa C, Jiménez JI. 2016. Properties of alternative microbial hosts used in synthetic biology: towards the design of a modular chassis. Essays Biochem 60:303–313. doi: 10.1042/EBC20160015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Martínez-García E, de Lorenzo V. 2019. Pseudomonas putida in the quest of programmable chemistry. Curr Opin Biotechnol 59:111–121. doi: 10.1016/j.copbio.2019.03.012. [DOI] [PubMed] [Google Scholar]
- 7.Newman JR, Fuqua C. 1999. Broad-host-range expression vectors that carry the l-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 227:197–203. doi: 10.1016/s0378-1119(98)00601-5. [DOI] [PubMed] [Google Scholar]
- 8.Shanks RMQ, Caiazza NC, Hinsa SM, Toutain CM, O’Toole GA. 2006. Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol 72:5027–5036. doi: 10.1128/AEM.00682-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Qiu D, Damron FH, Mima T, Schweizer HP, Yu HD. 2008. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl Environ Microbiol 74:7422–7426. doi: 10.1128/AEM.01369-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Meisner J, Goldberg JB. 2016. The Escherichia coli rhaSR-PrhaBAD inducible promoter system allows tightly controlled gene expression over a wide range in Pseudomonas aeruginosa. Appl Environ Microbiol 82:6715–6727. doi: 10.1128/AEM.02041-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shanks RMQ, Kadouri DE, MacEachran DP, O’Toole GA. 2009. New yeast recombineering tools for bacteria. Plasmid 62:88–97. doi: 10.1016/j.plasmid.2009.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Brothers KM, Stella NA, Hunt KM, Romanowski EG, Liu X, Klarlund JK, Shanks RM. 2015. Putting on the brakes: bacterial impediment of wound healing. Sci Rep 5:14003. doi: 10.1038/srep14003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
- 14.Liu Y, Rainey PB, Zhang XX. 2015. Molecular mechanisms of xylose utilization by Pseudomonas fluorescens: overlapping genetic responses to xylose, xylulose, ribose and mannitol. Mol Microbiol 98:553–570. doi: 10.1111/mmi.13142. [DOI] [PubMed] [Google Scholar]
- 15.Khlebnikov A, Datsenko KA, Skaug T, Wanner BL, Keasling JD. 2001. Homogeneous expression of the PBAD promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology 147:3241–3247. doi: 10.1099/00221287-147-12-3241. [DOI] [PubMed] [Google Scholar]
- 16.Khlebnikov A, Risa O, Skaug T, Carrier TA, Keasling JD. 2000. Regulatable arabinose-inducible gene expression system with consistent control in all cells of a culture. J Bacteriol 182:7029–7034. doi: 10.1128/jb.182.24.7029-7034.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Siegele DA, Hu JC. 1997. Gene expression from plasmids containing the araBAD promoter at subsaturating inducer concentrations represents mixed populations. Proc Natl Acad Sci U S A 94:8168–8172. doi: 10.1073/pnas.94.15.8168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Filloux A. 2011. Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution, and function. Front Microbiol 2:155. doi: 10.3389/fmicb.2011.00155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Qu Y, Olonisakin T, Bain W, Zupetic J, Brown R, Hulver M, Xiong Z, Tejero J, Shanks RM, Bomberger JM, Cooper VS, Zegans ME, Ryu H, Han J, Pilewski J, Ray A, Cheng Z, Ray P, Lee JS. 2018. Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis. JCI Insight 3:96914. doi: 10.1172/jci.insight.96914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Farinha MA, Kropinski AM. 1989. Construction of broad-host-range vectors for general cloning and promoter selection in Pseudomonas and Escherichia coli. Gene 77:205–210. doi: 10.1016/0378-1119(89)90068-1. [DOI] [PubMed] [Google Scholar]
- 21.Mi J, Sydow A, Schempp F, Becher D, Schewe H, Schrader J, Buchhaupt M. 2016. Investigation of plasmid-induced growth defect in Pseudomonas putida. J Biotechnol 231:167–173. doi: 10.1016/j.jbiotec.2016.06.001. [DOI] [PubMed] [Google Scholar]
- 22.Schweizer HP. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109–121. doi: 10.1016/0378-1119(91)90016-5. [DOI] [PubMed] [Google Scholar]
- 23.Sallam A, Kast A, Przybilla S, Meiswinkel T, Steinbuchel A. 2009. Biotechnological process for production of β-dipeptides from cyanophycin on a technical scale and its optimization. Appl Environ Microbiol 75:29–38. doi: 10.1128/AEM.01344-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Borrero-de Acuna JM, Hidalgo-Dumont C, Pacheco N, Cabrera A, Poblete-Castro I. 2017. A novel programmable lysozyme-based lysis system in Pseudomonas putida for biopolymer production. Sci Rep 7:4373. doi: 10.1038/s41598-017-04741-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Peng H, Zhang P, Bilal M, Wang W, Hu H, Zhang X. 2018. Enhanced biosynthesis of phenazine-1-carboxamide by engineered Pseudomonas chlororaphis HT66. Microb Cell Fact 17:117. doi: 10.1186/s12934-018-0962-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chakraborty R, Srinivasan M. 1992. Production and regulation of a thermostable protease by Pseudomonas sp. B45. Acta Microbiol Hung 39:181–191. [PubMed] [Google Scholar]
- 27.Prieto A, Escapa IF, Martinez V, Dinjaski N, Herencias C, de la Pena F, Tarazona N, Revelles O. 2016. A holistic view of polyhydroxyalkanoate metabolism in Pseudomonas putida. Environ Microbiol 18:341–357. doi: 10.1111/1462-2920.12760. [DOI] [PubMed] [Google Scholar]
- 28.Biniarz P, Coutte F, Gancel F, Łukaszewicz M. 2018. High-throughput optimization of medium components and culture conditions for the efficient production of a lipopeptide pseudofactin by Pseudomonas fluorescens BD5. Microb Cell Fact 17:121. doi: 10.1186/s12934-018-0968-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Henkel M, Geissler M, Weggenmann F, Hausmann R. 2017. Production of microbial biosurfactants: status quo of rhamnolipid and surfactin towards large-scale production. Biotechnol J 12:1600561. doi: 10.1002/biot.201600561. [DOI] [PubMed] [Google Scholar]
- 30.Jiang J, Zu Y, Li X, Meng Q, Long X. 2019. Recent progress towards industrial rhamnolipids fermentation: process optimization and foam control. Bioresour Technol 298:122394. doi: 10.1016/j.biortech.2019.122394. [DOI] [PubMed] [Google Scholar]
- 31.Sood U, Singh DN, Hira P, Lee JK, Kalia VC, Lal R, Shakarad M. 2020. Rapid and solitary production of mono-rhamnolipid biosurfactant and biofilm inhibiting pyocyanin by a taxonomic outlier Pseudomonas aeruginosa strain CR1. J Biotechnol 307:98–106. doi: 10.1016/j.jbiotec.2019.11.004. [DOI] [PubMed] [Google Scholar]
- 32.Punjabi K, Yedurkar S, Doshi S, Deshapnde S, Vaidya S. 2017. Biosynthesis of silver nanoparticles by Pseudomonas spp. isolated from effluent of an electroplating industry. IET Nanobiotechnol 11:584–590. doi: 10.1049/iet-nbt.2016.0172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Miller ES Jr, Peretti SW. 2002. Toluene bioconversion to p-hydroxybenzoate by fed-batch cultures of recombinant Pseudomonas putida. Biotechnol Bioeng 77:340–351. doi: 10.1002/bit.10071. [DOI] [PubMed] [Google Scholar]
- 34.Meisenzahl AC, Shapiro L, Jenal U. 1997. Isolation and characterization of a xylose-dependent promoter from Caulobacter crescentus. J Bacteriol 179:592–600. doi: 10.1128/jb.179.3.592-600.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Bhavsar AP, Zhao X, Brown ED. 2001. Development and characterization of a xylose-dependent system for expression of cloned genes in Bacillus subtilis: conditional complementation of a teichoic acid mutant. Appl Environ Microbiol 67:403–410. doi: 10.1128/AEM.67.1.403-410.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Miyoshi A, Jamet E, Commissaire J, Renault P, Langella P, Azevedo V. 2004. A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett 239:205–212. doi: 10.1016/j.femsle.2004.08.018. [DOI] [PubMed] [Google Scholar]
- 37.Nariya H, Miyata S, Kuwahara T, Okabe A. 2011. Development and characterization of a xylose-inducible gene expression system for Clostridium perfringens. Appl Environ Microbiol 77:8439–8441. doi: 10.1128/AEM.05668-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Noguchi Y, Kashiwagi N, Uzura A, Ogino C, Kondo A, Ikeda H, Sota M. 2018. Development of a strictly regulated xylose-induced expression system in Streptomyces. Microb Cell Fact 17:151. doi: 10.1186/s12934-018-0991-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wieland KP, Wieland B, Gotz F. 1995. A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for Staphylococcus carnosus. Gene 158:91–96. doi: 10.1016/0378-1119(95)00137-u. [DOI] [PubMed] [Google Scholar]
- 40.Eslani M, Movahedan A, Afsharkhamseh N, Sroussi H, Djalilian AR. 2014. The role of toll-like receptor 4 in corneal epithelial wound healing. Invest Ophthalmol Vis Sci 55:6108–6115. doi: 10.1167/iovs.14-14736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293–300. doi: 10.1128/JB.62.3.293-300.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33–38. doi: 10.1016/0378-1119(95)00685-0. [DOI] [PubMed] [Google Scholar]
- 43.Mukherjee S, Brothers KM, Shanks RM, Kadouri DE. 2015. Visualizing Bdellovibrio bacteriovorus by using the tdTomato fluorescent protein. Appl Environ Microbiol 82:1653–1661. doi: 10.1128/AEM.03611-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF, Russo CL. 2003. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 44:2496–2506. doi: 10.1167/iovs.02-0851. [DOI] [PubMed] [Google Scholar]
- 45.Block ER, Matela AR, SundarRaj N, Iszkula ER, Klarlund JK. 2004. Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling. J Biol Chem 279:24307–24312. doi: 10.1074/jbc.M401058200. [DOI] [PubMed] [Google Scholar]
- 46.Miller VL, Mekalanos JJ. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170:2575–2583. doi: 10.1128/jb.170.6.2575-2583.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Holloway BW. 1955. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13:572–581. doi: 10.1099/00221287-13-3-572. [DOI] [PubMed] [Google Scholar]
- 48.Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899–1902. doi: 10.1126/science.7604262. [DOI] [PubMed] [Google Scholar]
- 49.Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK, Gordon YJ. 2001. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology 108:1826–1829. doi: 10.1016/S0161-6420(01)00724-2. [DOI] [PubMed] [Google Scholar]
- 50.Deflaun MF, Tanzer AS, McAteer AL, Marshall B, Levy SB. 1990. Development of an adhesion assay and characterization of an adhesion-deficient mutant of Pseudomonas fluorescens. Appl Environ Microbiol 56:112–119. doi: 10.1128/AEM.56.1.112-119.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The annotated pMQ650 plasmid sequence has been deposited in GenBank under accession number MT344942. The DNA sequences of the xutR and Pxut regions from pMQ578, corresponding to genome coordinates 2656767 to 2656949 from the Pf0-1 genome, have been deposited in GenBank under accession number MN857504.